BRONCHODILATORS

Course overview

BRONCHODILATORS ARE INDICATED FOR INDIVIDUALS THAT HAVE LOWER THAN OPTIMAL AIRFLOW THROUGH THE LUNGS. THE MAINSTAY OF TREATMENT IS BETA-2 AGONISTS THAT TARGET THE SMOOTH MUSCLES IN THE BRONCHIOLES OF THE LUNG. VARIOUS RESPIRATORY CONDITIONS MAY REQUIRE BRONCHODILATORS, INCLUDING ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE. THEY ARE USED TO EITHER REVERSE ASTHMA SYMPTOMS OR IMPROVE LUNG FUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. THIS ACTIVITY REVIEWS THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, TOXICITY, DOSING, PHARMACODYNAMICS, AND MONITORING OF BRONCHODILATORS, PERTINENT FOR MEMBERS OF THE INTERPROFESSIONAL TEAM TO TREAT PATIENTS WITH OBSTRUCTIVE LUNG PATHOLOGY.